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The Plant-Derived Alkylamide, Hydroxy-Alpha-Sanshool, Induces
Analgesia through Inhibition of Voltage-Gated Sodium Channels
Makoto Tsunozaki1, Richard C. Lennertz2, Samata Katta1,
Cheryl L. Stucky2, Diana M. Bautistaa1.
1UC Berkeley, Berkeley, CA, USA, 2Medical College of Wisconsin,
Milwaukee, WI, USA.
Many native cultures use extracts from Xanthozylum plants to topically treat
toothache and joint pain. One active component of these extracts is the alkyla-
mide, hydroxy-a-sanshool, which induces tingling and numbing paresthesia
when applied to the skin or tongue. To understand the physiological mecha-
nisms underlying paresthesias, we sought to identify the molecular targets of
sanshool in the somatosensory system. We first measured the analgesic proper-
ties of sanshool using mouse models of somatosensory behavior. Topical appli-
cation of sanshool on the hind paw of naı¨ve mice did not alter their sensitivity to
noxious thermal or mechanical stimuli. However, in a model of neurogenic in-
flammation, sanshool acutely suppressed inflammatory hypersensitivity to me-
chanical force whereas it did not suppress hypersensitivity to heat. These data
suggest that sanshool inhibits activity of a subset of sensory neurons that trans-
duce mechanical, but not thermal, stimuli. In cultured dorsal root ganglion
(DRG) neurons from mice, sanshool inhibited action potential (AP) firing in
a subset of medium-to-large diameter neurons, which are thought to mediate
mechanotransduction. In contrast, sanshool did not inhibit AP firing in small-
diameter sensory neurons, which predominantly transduce noxious heat. In ad-
dition to size, sensory neurons are distinct in their expression of sensory
neuron-specific voltage-gated sodium channels. Thus the differential effect of
sanshool on sensory neurons may be due to selective activity of sanshool on
different sodium channels. To test this idea, we compared the effects of san-
shool on two sodium channel subtypes that are expressed in sensory neurons,
Nav1.7 and 1.8. Sanshool reduced the magnitude of Nav1.7 and Nav1.8 cur-
rents but caused a hyperpolarizing shift in the steady-state inactivation curve
of Nav1.7 only. Thus intrinsic molecular differences between sensory neurons,
such as expression of different sodium channel subtypes, may underlie specific-
ity of sanshool action.
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Unique Type of Sodium Channel Inhibition by Riluzole
Arpad Mike1, Krisztina Pesti1, Balazs Sas1, Steffen B. Schulz2.
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2Charite´ Universita¨ts-medizin Berlin, Institute of Neurophysiology,
Berlin, Germany.
Riluzole is a persistent-selective sodium channel inhibitor (SCI), which has
a therapeutic potential to treat several neurological and psychiatric disorders.
SCIs form a large and diverse group, which includes widely different modes
of action. Individual SCIs may be very potent in one protocol, but ineffective
in another. We have developed a method for testing the ‘‘personality’’ of
SCIs, i.e., we assess their potency under different voltage protocols. The pattern
of their relative potencies gives a characteristic fingerprint which shows correla-
tion with specific chemical properties of molecules, and may also predict their
therapeutic profile. We have identified distinct modes of action for specific
groups of SCIs. Riluzole was found to have a unique ‘‘personality’’ type; there-
fore, in this study we performed a detailed analysis of its mode of action. The
classic SCIs lidocaine and carbamazepine as well as the persistent-selective ra-
nolazine were used as reference compounds.We observed a paradoxical inverse
use-dependence and an apparent transient facilitation on sodium channels in the
presence of riluzole (but not of other drugs) when currents were evoked by short
depolarizations: in such protocols, riluzole appeared to be ineffective. On the
other hand, in protocols with prolonged moderate depolarizations the drug
was remarkably potent; suggesting that it strongly enhanced closed state inacti-
vation. Recovery from fast inactivation was significantly impeded by riluzole,
while recovery from slow inactivated state was - remarkably - even slightly ac-
celerated.As a possiblemechanismwepropose that riluzole has an exceptionally
fast binding kinetics, a high affinity for pre-open closed- and fast inactivated
states, while a low affinity for slow inactivated state.
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Molecular Determinants of Human Voltage-Gated Sodium Channels
Blockade by Lubeluzole
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Chemistry, University of Bari, Bari, Italy.Lubeluzole displays neuroprotective activity in vitro and in vivo. Blockade of
sodium channels (NaCh) was proposed as a main mechanism for preclinical
and clinical efficacy. We studied the molecular determinants for lubeluzole ac-
tion on whole-cell sodium currents in HEK293 cells expressing hNav1.4
NaChs, using patch clamp technique. Lubeluzole and derivatives were synthe-
sized in our laboratories. Effect of racemic lubeluzole and enantiomers on
NaChs was dose- and use-dependent, with IC50 values of 30 mM at 0.1 Hz stim-
ulation frequency and 2 mM at 10 Hz using an holding potential (hp) of 120
mV. These are ~8 and ~18 times lower than the respective IC50 values for the
well-known NaCh blocker mexiletine. The affinity of lubeluzole for the closed
(KR) and inactivated channel (KI) were 840 and 0.03 mM, compared to 800 and
2 mM for mexiletine. Use-dependent block by lubeluzole was inhibited only
partially by F1586C mutation at the local anesthetic molecular receptor, sug-
gesting that lubeluzole may bind at a different but overlapping receptor. Indeed
KR and KI values for lubeluzole binding to F1586C channel were 700 and 0.7
mM. To go further in details, we synthesized two lubeluzole derivatives, each
containing about one half of the parent compound. The aryloxypropanolamine
moiety recalls the structure of clenbuterol, while the benzothiazole moiety is
similar to riluzole, both known NaCh blockers. However, both derivatives dis-
played very poor use-dependent block, with IC50 values greater than 800 mM at
the hp of 120 mV. In conclusion, lubeluzole is a very potent blocker of inac-
tivated sodium channels, which explains its huge use-dependent action. Lube-
luzole probably utilizes binding interactions distinct from those of local
anesthetic-like drugs, which may open the way for the development of new
compounds with peculiar activity on sodium channels (Supported by Tele-
thon-Italy).
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Ranolazine inhibits the increased persistent Naþ current (persistent INa) con-
ducted by NaV1.1 channels encoding epilepsy and migraine associated muta-
tions. We therefore determined the effects of ranolazine on the electrical
activity of cultured rat hippocampal neurons using empirical and computa-
tional modeling approaches. Ranolazine (3mM) produced a 24% reduction
in the number of action potentials (APs) evoked in response to repetitive
(1sec, 0.67Hz) depolarizing current injections (2154 for control and 1653
for ranolazine, pulse 9, p<0.05). With a single current injection of 4sec,
spike cessation occurred at 24035220 msec in the presence of 10mM rano-
lazine (400050 msec for control). Similar results were observed for the an-
ticonvulsants phenytoin (3mM, 13875184 msec) and lacosamide (30mM,
2441553 msec), which bind to fast and slow-inactivated states of Naþ chan-
nels, respectively. Ranolazine enhanced the development of Naþ channel fast
and slow inactivation evaluated with conditioning pre-pulses of either 100,
1000 or 10000 msec, consistent with progressive binding to inactivated states.
Recovery of Naþ channel activity assessed using fast and slow inactivating
voltage protocols was also delayed in the presence of ranolazine. Interest-
ingly, the use-dependent inhibition (25Hz) of Naþ channel activity by rano-
lazine (10mM) was dependent on the duration of the voltage step (3.052.0%
for 2ms and 33.8513.5% for 20ms, p<0.05) suggesting the drug bound to
inactivated state(s). Similar to phenytoin, ranolazine exhibited slow binding
kinetics to HEK293 cells stably expressing hNav1.2 (KON= 1M
1msec1
and KOFF= 5e
5msec1). Computational simulations predicted equal inhibi-
tion of neuronal APs regardless of whether ranolazine binding was con-
strained to fast-inactivated or slow-inactivated states of the Naþ channel.
Ranolazine had no or minimal effects on neuronal KV channels, GABA or
NMDA neurotransmission. In summary, ranolazine inhibits the excitability
of hippocampal neurons by slowly stabilizing the inactivated states of Naþ
channels.
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Ranolazine Effects on NaV1.2 and Modulation by pH
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Ranolazine is an anti-anginal drug previously shown to block persistent cur-
rents of the cardiac voltage gated sodium channel, NaV1.5. The effects of ra-
nolazine, however, have not yet been described in all sodium channel
isoforms. We studied the effects of ranolazine on the neuronal sodium channel
isoform, NaV1.2, and its modulation by extracellular protons. Ionic currents
were measured from Chinese Hamster Ovary (CHO) cells expressing the
324a Monday, February 27, 2012a-subunit of NaV1.2, using whole cell patch clamp techniques. Voltage pro-
tocols were run with extracellular solutions of pH 7.4 and pH 6.0 before
and after the addition of ranolazine. The addition of 100 mM ranolazine at
pH 7.4 led to a significant decrease in late sodium current, faster rate of
open state fast inactivation, and slower recovery from inactivation. Similar
trends were seen in preliminary experiments at 10 mM and 30 mM ranolazine.
In addition, we observed a tonic block of peak current and an increase in total
use-dependent block. Many of these effects were different at low pH. Low pH
led to a significant depolarizing shift of the conductance curve, and slowed the
onset of fast inactivation. Adding ranolazine at pH 6.0 significantly decreased
the rate of fast inactivation recovery, and increased the total use-dependent
block and rate of open state inactivation. Although directions of the effects
were unchanged, the magnitude of these effects was significantly different be-
tween the two pH values. Our results suggest that ranolazine stabilizes fast in-
activation at both pH 7.4, and pH 6.0. It is possible that ranolazine and protons
may compete for a common binding site or indirectly interact leading to de-
creased ranolazine efficacy at low pH. (Supported by a research grant from Gi-
lead Sciences, Inc. and an NSERC Discovery Grant to PCR, and an NSERC
URSA to CHP.)
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Contribution of Local Anesthetic Binding Site Residues F1760 and Y1767
to Block of the Cardiac NaD Channel, hNaV1.5, by Ranolazine
KimW. Chan, Dennis Tabuena, Cheng Xie, John Shryock, Luiz Belardinelli,
Catherine Smith-Maxwell.
Gilead Sciences, Palo Alto, CA, USA.
Amino acid residues F1760 and Y1767 in S6/Domain IV of voltage gated Naþ
channels are part of the local anesthetic binding site in the inner mouth of the
pore. Mutagenesis experiments have shown that use-dependent block (UDB)
of the cardiac hNaV1.5 Na
þ channel by the Class Ia anti-arrhythmic drug lido-
caine is significantly reduced by alanine substitutions at these two sites. The
antianginal drug ranolazine, which has structural similarity to lidocaine, was
shown previously to block the cardiac late sodium current (INa) and to block
peak and late INa in a use-dependent manner (Rajamani et al., 2009). As
with lidocaine, UDB of peak INa by ranolazine was reduced in the F1760A mu-
tant channel (Fredj et al., 2006; Wang et al., 2008). We used the F1760A and
Y1767A mutants to investigate further the block by ranolazine of the closed,
inactivated, and open states of the channel. To measure affinity to the open
state, we used an inactivation-deficient hNaV1.5 channel (L409C/A410W,
Edrich et al., 2005) in the presence and absence of the F1760A or Y1767A mu-
tations. We found that both mutations (F1760A and Y1767A) significantly de-
creased UDB of peak INa, block of the open state, and block of late INa by
ranolazine compared to WT channels (14-24 fold shift of the value of IC50
for ranolazine). The effect of the mutations on block by ranolazine of the rest-
ing and inactivated states was modest (1.3-1.9 fold shift of the value of IC50
for ranolazine). The results indicate that both the F1760A and Y1767A muta-
tions reduce the effect of ranolazine to cause UDB and open state block of
hNaV1.5.
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Using Full Factorial Design of Experiments on an Automated Patch Clamp
Instrument: A Case Study on the Ionworks Quattro and Nav1.5 Channel
Yan T. Lee1, Andrew P. Golden2, Mats Holmqvist3, W. Adam Hill1,
Laszlo Urban1, Gul Erdemli1.
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In the past decade, technological advancements have enabled automation of
patch clamp recordings. Instruments like the Ionworks Quattro produces elec-
trophysiological data from a 384 well plate in about an hour. However, they
also require proprietary and expensive one-use consumables like the Patch-
Plate. Conversely, the large amount of data produced from these instruments
also allows more than the ‘‘one factor at a time’’ experiments. Here we present
an example of a full factorial experiment on the Nav1.5 channel using the Ion-
works Quattro. A full factorial experimental design provides more information
about the instrument by having a more precise estimation of each factor alone
and by estimating the interactions between factors.
We tested the potencies of several known blockers on the cardiac sodium chan-
nel (Nav1.5) and varied 3 factors: incubation time, mixing cycles, and cell den-
sity. From the experiment, we find that the IC50s of most compounds are
affected by incubation time and cell density. We also observed interactions
with the factors of incubation time/cell density and the number of mixing cy-
cles/cell density. From this case study, we propose that a factorial design of ex-
periments can be done effectively with an automated patch clamp instrument to
optimize assay conditions with enriched information to the effect of reduction
of consumables and shortened time of assay development.1646-Pos Board B416
Functional Studies of Interaction Between Huwentoxin-IV and Voltage-
Gated Sodium Channel Nav1.7
Amy Y. Shih, Scott Bembenek, Natali Minassian, Robert Neff, Yi Liu,
Mack Flinspach, Suzanne Edavettal, Nyantsz Wu, Michael Maher,
Alan Wickenden, Taraneh Mirzadegan.
Johnson & Johnson, San Diego, CA, USA.
Voltage-gated sodium channel 1.7 (Nav1.7) plays a role in the conduction of
action potentials and is involved in the sensation of pain. Spider toxins such
as Huwentoxin IV (HwTx-IV) are potent inhibitors of Nav1.7, functioning as
a gating modifier trapping the voltage sensor in an inward closed conformation.
HwTx-IV interacts with specific residues in the voltage sensor S3-S4 region of
domain II. The purpose of the present study was to understand the residues im-
portant for interaction between HwTx-IV and Nav1.7. Computationally, mo-
lecular dynamics was used to study wild type HwTx-IV along with various
alanine and cystine mutations to determine residues important for the stability
of toxin and to obtain a model of the interacting surface. A homology model of
Nav1.7 was built and the toxin docked to determine key interactions. Experi-
mentally, alanine mutants of HwTx-IV were tested for functional activity using
FLIPR, QPatch, and manual patch. Computational and experimental results
suggest key residues critical for binding of the toxin to Nav1.7, particularly
S25, W30 and K32. These studies provide a more clear idea of the nature of
interaction between HwTx-IV and Nav1.7 and may therefore be a useful guide
in designing novel peptides with improved selectivity for sodium channel
subtypes.
1647-Pos Board B417
‘‘Clip Detecting’’ with Series Resistance Compensation using an Auto-
mated Patch Clamp System
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One of the significant challenges for automated patch clamp has been to in-
corporate amplifiers with the ability of adjusting to changes in membrane ca-
pacitance, series resistance (Rs) and voltage-clamp time constants without
user intervention. If these adjustments are not made correctly there is
a risk of generating un-precise data or even losing data due to oscillations
in the recorded trace. Rs compensation capability of the patch clamp ampli-
fier of QPatch is presented. A new ‘‘clip detector feature’’ allowing Rs to be
temporarily turned off avoiding loss of cells due to fatal oscillations, and
thereby increasing the data throughput while maintaining high quality record-
ings, is presented. Clamping whole-cells can be a challenge depending on the
magnitude of Rs. The series resistance produces two undesired effect on
whole cell voltage clamp recordings: i) The cells not being clamped to the
desired potential due to the voltage drop over the Rs (Vdrop= Rs x I), ii)
The resolution of the voltage clamp in fast physiological processes being af-
fected by the Rs. It is essential to reach adequate series compensation in
a timely manner to obtain accurate recordings. As such, the quality of data
depends on the quality of the patch clamp amplifier and its features. In order
to make fast 100% series resistance compensation a fast patch clamp ampli-
fier is needed. The embedded amplifier in the QPatch utilizes a patented tech-
nique invented by Adam Sherman (Alembic Instruments). QPatch data from
human SK potassium and fast sodium channels are shown. The data demon-
strates that i) QPatch measures the fastest sodium channels with accurate
clamp, and ii) the patch clamp amplifier in QPatch has the required speed
to record the correct current amplitude when the current through an open
SK channel is reversed.
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Inhibition of Voltage-Gated NaD Currents in Sensory Neurons by the Sea
Anemone Toxin APETx2
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ASICs are neuronal Hþ-gated channel that are transiently opened by extracel-
lular acidification. Functional ASIC channels are made of homotrimeric or het-
erotrimeric complexes of different ASIC subunits (ASIC1a, 1b, 2a, 2b
and 3). APETx2, a toxin from the sea anemone Anthropleura elegantissima in-
hibits homotrimeric ASIC3 with IC50<100 nM. In rat sensory neurons (DRG),
where heterotrimeric channels are expressed, higher concentration are neces-
sary to block ASIC3 containing channels (0.1-2mM). Several animal studies re-
lied on APETx2 as a selective pharmacological tool to study ASIC3
physiological role.
